This study investigated the effects of cinnamaldehyde in combatting the hyphal growth of Candida albicans under varying concentrations, treatment times, and temperatures to determine the potential benefits of applying this substance to anti-Candida foods or gargles. From the results of pretreatment with cinnamaldehyde against Candida hyphae, we found that its inhibitory activity seemed to be strengthened in parallel with prolonged pretreatment time and a rise in temperature, and that pretreatment of 2,000 µg/ml for only 1 minute significantly inhibited the hyphal growth of C. albicans. We also demonstrated by XTT assay that pretreatment with cinnamaldehyde affected the metabolic activity of Candida hyphal cells. These findings suggest that a warm drink or mouthwash containing cinnamaldehyde might be a candidate as a prophylactic or therapeutic tool against oral Candida infection.
Introduction
Candida albicans, a dimorphic fungus, is a member of the oral microbial flora in healthy human individuals, frequently and opportunistically growing excessively and becoming the causative agent of oral candidiasis 1, 2) . The hyphal form of C. albicans can invade human mucosal tissue, and exert its pathogenicity 3, 4) . Pathogenic symptoms of oral candidiasis accompanied by severe inflammation aggravate the quality of life of immunosuppressed individuals and elderly people 5, 6) .
Since spices and herbs have traditionally been used as anti-microbiological tools in daily life throughout the world, we and our colleagues have investigated their anti-Candida activity to develop new therapies 7−9) .
Previously, we reported that a cassia(Cinnamomum cassia)preparation inhibited hyphal growth of C. albicans and exerted a therapeutic effect on a murine oral candidiasis model 9, 10) .
Additionally, the results of gas chromatography / mass spectrometry(GC/MS)analysis suggested that cinnamaldehyde is the major component of the essential oil of cassia, and that it was responsible for the inhibitory activity in the cassia preparation 9) .
In the present study, we examined the effect of cinnamaldehyde against hyphal growth of C. albicans under varying treatment times(from 1 to 60 minutes)and temperature conditions when applied to preparation of an anti-Candida food or gargle. We speculate that if an herbal material such as cassia preparation can be developed as a candy, drink, or gargle with a clinically therapeutic function against oral candidiasis, its active principle would need to display antifungal activity by limited term interaction with C. albicans. We also examined the metabolic activity of Candida cells after treatment with cinnamaldehyde.
Here we report that the inhibitory activity of cinnamaldehyde against Candida hyphal growth tends to be strengthened by prolonged pretreatment time and higher temperature condition, and that even a 1 minute pretreatment with this substance exerts an inhibitory activity against Candida cells and affects their metabolic activity.
Materials and Methods
C. albicans strain C. albicans TIMM1768 was used in this study. The strain was grown on Sabouraud dextrose agar plate for 18h at 37ºC. Cells were harvested with a microspatula and suspended in RPMI1640 medium containing 2.5% fetal calf serum(RP medium) . The suspension of C. albicans was used as the inoculum for all subsequent experiments 9, 11) .
Preparation of cinnamaldehyde
Cinnamaldehyde was purchased from Wako Pure Chemical Industries, Ltd.(Osaka, Japan) and dissolved in dimethylsulfoxide(DMSO)at 10% (w/w)prior to dilution with RP medium as described previously 8, 9) Measurement of activities of cinnamaldehyde against Candida hyphal growth Inhibitory activity of cinnamaldehyde against Candida hyphal growth was assessed by a crystal violet(CV)staining method as described previously 11−13) . In brief, Candida cells were seeded in a 96-well flat bottom microplate at 5 × 10 3 cells/ml in a volume of 200µl RP medium and preincubated for 3 hours at 37ºC in a 5% CO2 atmosphere. After the microscopic observation of Candida growth, the medium was aspirated, and then 200µl of the cinnamaldehyde preparation was loaded onto the microplate and incubated at 37, 40, 42.5, and 45ºC for 1, 20, 40, and 60 minutes. The conditions of pretreatment time and temperature were established on the assumption that cinnamaldehyde is used in gargles and foods such as candy, chewing gum, and spiced tea 10, 14) . (Since it is reported that humans perceive heat stimuli(＞= 46ºC)as unpleasant contact, temperature conditions were set at less than 45ºC 15−17) .)
The sample solution was removed and each well was washed twice with RP medium. Then 200µl of RP medium was loaded onto the microplate and incubated for 14 to 15 hours at 37ºC in a 5% CO2 atmosphere. The medium in the wells was discarded by inverting the microplate. Hyphal cells of C. albicans which adhered to the bottom of the wells were sterilized by treatment with 70% ethanol and stained with 0.01% CV. The microplate was washed with water and dried, and then 150µl of isopropanol containing 0.04N HCl and 50µl of 0.25% sodium dodecyl sulfate was added to the wells and mixed. The absorbance at 620 nm of quadruplicate samples was measured spectrophotometrically.
Metabolic activity measurement of Candida cells treated with cinnamaldehyde
Metabolic activity of Candida cells incubated for 1, 20, 60 minutes with varying concentrations of cinnamaldehyde was measured by XTT［2,3-bis (2-methoxy-4-nitro-5-sulfophenyl) -2H-tetrazolium-5-carboxanilide sodium salt］assay as described previously 18−22) . Briefly, Candida cells prepared at 5 × 10 5 cells/ml in RP medium were treated with cinnamaldehyde preparation using the same method as in the crystal violet assay. Two hundred µl of XTT solution was added and incubated at 37ºC for 2. 5 hours. The plate was centrifuged(1,500 rpm, 1 min)and 100µl of supernatant in each well was placed in a new well. The absorbance at 450 nm of quadruplicate samples was measured spectrophotometrically.
Results
Inhibitory activities of cinnamaldehyde against C. albicans hyphal growth under the various experimental conditions Inhibitory activities of cinnamaldehyde against growing hyphae of C. albicans after treatment for 20, 40, and 60 minutes at 37, 40, 42. 5, 45ºC were examined by CV staining method, and the results are shown in Table 1 .
Inhibitory activity of each preparation was compared by IC50, the concentration of cinnamaldehyde which reduced growth of C. albicans by 50% for the non-treatment group(control) . IC50 of the 20 minute pretreatment at 37ºC was 320-800 µg/ml. When pretreatment time was prolonged to 40 or 60 minutes at the same temperature, IC50 for both periods was decreased to 128-320µg/ml. It was also shown that IC50(128-320 µg/ml)of the 20 minute pretreatment at 40ºC was lower than IC50 (320-800µg/ml)at 37ºC. In the 60 minute pretreatment, IC50(51.2-128µg/ml)at 40ºC was lower than IC50(128-320µg/ml)of the same pretreatment time at 37ºC. IC50 at 42.5 and 45ºC was at almost the same level as that of the 40 minute pretreatment, but that at 45ºC(51.2-128µg/ml)was the same as IC50 of the 60 minute pretreatment at 42.5 and 45ºC. These results show that the inhibitory activity of cinnamaldehyde against Candida mycelial growth tends to be enhanced by prolonged pretreatment time and rising temperature.
Using the CV staining method (Table 2) , we also evaluated the inhibitory activity of cinnamaldehyde against Candida hyphae for 1 minute to Inhibitory activityof cinnamaldehyde for Candida hyphal growth was measured by CV staining method as described in Materials and Methods. Each group was treated with 2,000 or 800µg/ml of cinnamaldehyde for 1 minute at 37, 40, 42.5 and 45ºC, respectively. Results are shown as the relative value of Candida hyphal growth under each pretreatment condition for non-pretreatment group (100%).
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determine its efficacy using a pretreatment time shorter than 20 minutes.
Since 1 minute pretreatment with 800 µg/ml of cinnamaldehyde at 37ºC did not inhibit hyphal growth significantly in preliminary experiments, we examined its inhibitory activity at the concentrations of 800 and 2,000 µg/ml at 37, 40, 42.5, 45ºC. The inhibitory activity of 1 minute pretreatment against Candida hyphal growth was shown as the relative growth of Candida hyphae of each pretreatment group to the non-pretreatment group (control) . While the pretreatment with 800µg/ml cinnamaldehyde for 1 minute at 37ºC did not inhibit the hyphal growth of C. albicans, pretreatment with the same dose at 45ºC lowered the growth of these hyphae to 68.1%.
With 2, 000µg/ml pretreatment, Candida hyphal growth was lowered to 6. 26% at 37ºC; further, growth of these hyphae pretreated with the same amount of material at 45ºC was inhibited to 2.83%.
These data indicate not only that the inhibitory activity of cinnamaldehyde seemed to be strengthened by prolonged pretreatment time and rising temperature, but also that 2, 000µg/ml of this substance strongly inhibited hyphal growth of C. albicans, when preincubated with it even for 1 minute.
Metabolic activity of Candida cells treated with cinnamaldehyde
Effects of pretreatment with cinnamaldehyde on the metabolic activity of C. albicans hyphal cells were also examined by XTT assay. Table 3 shows that metabolic activity of these cells decreased from 95. 1%(128µg/ml, 1 minute, 37ºC)to 6.64%(2,000 µg/ml, 60 minutes, 45ºC) , and tended to decrease in a time-or dose-dependent manner at 37ºC and 45ºC. Comparing the metabolic activity at 37 and 45ºC, the hyphae treated at 45ºC seemed to be lower than the corresponding values at 37ºC.
The results also show that metabolic activity of Candida cells treated with 2000 µg/ml cinnamaldehyde for 1 minute decreased to 65.7% at 37ºC, and the hyphal growth after 1 minute pretreatment at 45ºC(56.0%)was lower than the corresponding value at 37ºC. The results of XTT assay demonstrate that even 1 minute pretreatment of cinnamaldehyde lowered the metabolic activity of Candida albicans and this effect seemed to be stronger at 45ºC.
Discussion
We examined the inhibitory activity of cinnamaldehyde pretreatment against Candida hyphal growth at varying times and temperatures, since this material has been a part of the regular diet in cooked foods and teas in many countries throughout the ages 23) .
In this study, we demonstrated that pretreatment of C. albicans with cinnamaldehyde(2, 000 µg/ml) for just 1 minute, exerted an inhibitory activity on its hyphal growth. The dose of 2, 000 µg/ml seems somewhat higher than that usually intaken in daily life, but this concentration has been reported as safe to be consumed 9, 10, 24) .
The results of CV staining and XTT assay showed that the inhibitory activity of cinnamaldehyde seemed to be strengthened in parallel with a rise in temperature in warm tea which is not rejected for its unpleasant temperature effect 16, 17) . In the previous study, we reported that oral administration of 50µl of a solution with 19.5 mg/ml of cinnamaldehyde or cassia which contained 19.5 mg/ml of cinnamaldehyde exerted a therapeutic activity against murine oral candidiasis 9, 11) . This effective concentration is about 10 times that of the 2,000µg/ml effective in vitro in the pretreatment assay. We do not believe that this difference is strange because oral administration would be followed by diffusion in the oral cavity 7, 9, 10) . It is also our opinion that the temperature dependence on cinnamaldehyde effects in vitro suggest that oral intake of a hot food or beverage containing this substance such as spiced tea in daily life may be one of the more effective methods of inhibiting Candida hyphal growth. It now appears to us necessary that in order to realize the successful application of cinnamaldehyde to combat human oral candidiasis, we must examine other optimal conditions, such as optimal pH, physical condition, potentiation of the effects of cinnamaldehyde in combination with other food agents and details of interaction between cinnamaldehyde and Candida albicans 10, 23, 25) . It is our hope that these studies will facilitate development of the application of spices and herbs in daily use to prevent and improve the problem of oral candidiasis in elderly and immunocompromised patients.
